Small Cell Lung Cancer | Proceedings From Our Small Cell Lung Cancer Webinar

Introduction (0:00) Case: A woman in her late 60s with newly diagnosed extensive-stage small-cell lung cancer (ES-SCLC) who receives carboplatin/etoposide/atezolizumab — Luis Paz-Ares, MD, PhD (13:22) Case: A woman in her mid-40s with newly diagnosed ES-SCLC who receives carboplatin/etoposide/durvalumab — Jared Weiss, MD (29:43) Case: A man in his early 60s with ES-SCLC who receives carboplatin/etoposide/durvalumab and then experiences disease progression — Dr Paz-Ares (38:08) Case: A man in his early 70s with progressive SCLC who receives lurbinectedin — Dr Paz-Ares (45:15) Case: A man in his early 80s with SCLC who experiences disease progression — Dr Weiss (54:46) CME information and select publications